Drawing for DAYMARK

USPTO serial 98680781

DAYMARK

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
HOFFMAN, CHRISTOPHER J
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with DAYMARK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,143*

Plus Government fees of $1,050

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lindsay Cohen Schneider

Lindsay Cohen Schneider BRYAN CAVE LEIGHTON PAISNER LLP211 N BroadwaySuite 3600St. Louis, MO 63102

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for health care management and social services care management for cancer patients; downloadable computer software for coordinated and comprehensive medical, social care, and care management for cancer patients, with access to patient electronic health records and medical care, patient data obtained through remote patient monitoring and self-reporting, and information and records related to patients' social care needs, accessible by patients, caregivers, providers, and community benefit organizations; downloadable mobile application software for health care management and social services care management for cancer patientsACTIVE—
035Organizing and developing charitable projects that aim to promote awareness of early treatment of cancer; promoting public interest and awareness of cancer research, treatment, and education; pharmaceutical cost management services and drug utilization review services; business monitoring and business consulting services in the fields of medicine and health care, namely, health care utilization and review services, particularly specializing in the use of analytic and statistic models for the understanding and predicting of trends pertaining to cancer prevention, screening, diagnosis and treatment for business purposes; business services in the field of hospital operations management, namely, management of ambulatory infusion services for existing hospitals and hospital systemsACTIVE—
036Insurance services, namely, underwriting, issuance and administration of health insurance for cancer patients; administration of health care insurance plans for cancer patients; issuance of health insurance for cancer patients; health insurance administration for cancer patients; providing advice or consultation regarding health insurance or financial employee benefit plans for cancer patients; conducting fundraising campaigns to support cancer research, treatment, and education; administration of health savings accounts for cancer patients; pharmaceutical benefit management services; guidance, namely, providing information in the field of medical insuranceACTIVE—
041Arranging and conducting seminars, classes, workshops, courses of instruction, vocational guidance, educational guidance being coaching, and training in the field of oncology; arranging and conducting seminars, classes, workshops, courses of instruction, vocational guidance, educational guidance being coaching, and training in the fields of health, cancer, cancer recovery and survival, cancer prevention, screening, diagnosis and treatment, medical services, pharmaceuticals, health care, medical insurance and benefits, caregiving, and social servicesACTIVE—
042Providing internet-based non-downloadable software for care management and social services care management for cancer patients; medical research in the field of oncology; medical research in the field of cancer; platform as a service (PAAS) featuring computer software platform for coordinated and comprehensive medical, social care, and care management for cancer patients, with access to patient electronic health records and medical care, patient data obtained through remote patient monitoring and self-reporting, and information and records related to patients' social care needs, accessible by patients, caregivers, providers, and community benefit organizationsACTIVE—
044Medical services in the fields of oncology, medication management, care delivery, and care decision processes; health care services for the treatment of cancer; medical services for the treatment of cancer; mobile medical services in the fields of oncology, medication management, care delivery, and care decision processes; home health care services in the fields of cancer prevention, screening, diagnosis, treatment, survivorship medical care, and end-of-life medical care; medical services for elderly patients; telemedicine services; medical imaging services for cancer patients; medical radiology and diagnostic imaging services; medical diagnosis, evaluation, and treatment of cancer; providing links to the web sites of others featuring information about the diagnosis and treatment of cancer; providing information in the fields of cancer prevention, screening, diagnosis and treatment; rehabilitation patient care services; managed health care services for cancer patients; geriatric health care management services for cancer patients; consulting in the fields of health, wellness, and nutrition for cancer patients; cancer screening services; remote monitoring of medical data for medical diagnosis and treatment; health care services, namely, disease management programs; palliative care services; consultation services in the field of palliative care; consulting services in the field of oncology health care; health care consulting in the fields of cancer prevention, screening, diagnosis and treatment; health care consulting in the fields of value-based care for value-based oncology care; consulting services in the fields of medicine and health care particularly specializing in the use of analytic and statistic models for the understanding and predicting of trends pertaining to cancer prevention, screening, diagnosis and treatment; guidance, namely, providing information in the fields of oncology, health, cancer, cancer recovery and survival, cancer prevention, cancer screening, cancer diagnosis and treatment, medical services, therapeutic properties of pharmaceuticals, health care, and caregiving in the nature of providing healthcareACTIVE—
045Social services, namely, coordinating medical, physical, social, personal care services for oncology patients; providing case management services, namely, coordinating medical, physical, legal, social, personal care, psychological and transitional care services with health care providers for oncology patients; oncology care management services in the nature of the coordination of necessary services and personal care for oncology patients and their caregivers; support services to oncology patients and their caregivers, namely, coordination of medical, physical, legal, social, and personal care services for said individuals; social services, namely, companionship services for oncology patients and their caregivers; providing case oncology care management services, namely, coordination of necessary medical services for oncology patients related to acute and chronic health conditions, oncology treatments, infusion therapy services, and anti-infective infusion services; providing personal support services for patients and families of patients with cancer, namely, emotional counselling and emotional support; providing emotional support to cancer patients and their families via interactive online forums; consulting services in the field of patient support services, namely, consulting related to case management services in the nature of coordinating medical care; providing patient advocate services in the fields of long-term care, cancer treatment, oncology, specialty pharmacy services, and ambulatory care; providing patient advocate and case management services, namely, coordinating the procurement and administration of medications for oncology treatment and infusion therapy services; providing a website via a global computer network featuring supportive personal stories on the subjects of health, cancer, cancer recovery and survival; guidance, namely, providing social services information about the coordination of medical, physical, legal, social, personal care, psychological and transitional care services with health care providers for oncology patientsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 19, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 18, 2026EX2GSOU EXTENSION 2 GRANTED—
May 18, 2026EXT2SOU EXTENSION 2 FILED—
May 18, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 4, 2025EX1GSOU EXTENSION 1 GRANTED—
Nov 4, 2025EXT1SOU EXTENSION 1 FILED—
Nov 4, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 20, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 25, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 25, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 19, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 2, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 2, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Mar 2, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 2, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 2, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 20, 2025DOCKASSIGNED TO EXAMINER—
Feb 19, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance